APEA WOMEN’S HEALTH FINAL EXAM AND PRACTICE EXAM
NEWEST 2026 TEST BANK| WOMEN’S HEALTH APEA FINAL
EXAM PREP WITH COMPLETE REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST
RECENT!!)
Core Domains
1. Reproductive Anatomy and Physiology
2. Contraception and Family Planning
3. Menstrual Disorders and Menopause
4. Gynecologic Infections and Sexually Transmitted Infections
5. Breast Health and Cervical Screening
6. Obstetrics: Prenatal Care and Pregnancy Complications
7. Structural Disorders, Sexual Health, and Primary Care Integration
8. Health Promotion and Preventive Care
9. Pharmacology and Therapeutic Interventions
10. Clinical Decision-Making and Diagnostic Interpretation
Introduction
This comprehensive assessment is designed to evaluate the knowledge, clinical judgment, and applied
decision-making required of a Women’s Health Nurse Practitioner preparing for the APEA Women’s
Health Final Examination. It rigorously tests foundational reproductive physiology, contraception,
menstrual disorders, menopause management, sexually transmitted infections, breast and cervical
health, prenatal care, obstetric complications, and primary care integration. The exam employs multiple-
choice and scenario-based questions emphasizing real-world clinical application, evidence-based
guidelines, and critical thinking. Mastery of these domains is essential for competent women’s health
practice and certification success.
SECTION ONE: QUESTIONS 1–350
1. A 24-year-old patient asks about the timing of ovulation in her menstrual cycle. Which hormone
surge triggers the release of the mature oocyte from the dominant follicle?
,A. Estrogen surge on day 7
B. Luteinizing hormone (LH) surge approximately 24–36 hours before ovulation
C. Progesterone surge during the luteal phase
D. Follicle-stimulating hormone (FSH) surge at menstruation
RATIONALE: The midcycle LH surge, triggered by rising estrogen levels from the dominant follicle,
induces final oocyte maturation and follicular rupture. This surge is the immediate trigger for ovulation
and can be detected by urine ovulation predictor kits.
2. A patient with primary amenorrhea has normal breast development but no pubic or axillary hair.
Which condition should be suspected?
A. 21-hydroxylase deficiency
B. 5-alpha reductase deficiency
C. Androgen insensitivity syndrome (46,XY karyotype with absent androgen receptor function)
D. Aromatase deficiency
RATIONALE: Androgen insensitivity syndrome presents with normal breast development (estrogen
from testicular aromatization) but absent androgen-dependent hair growth. Internal structures are
male; external genitalia appear female due to unresponsiveness to androgens.
3. During a pelvic examination, the provider palpates a firm, muscular structure between the bladder
and rectum. This structure is:
A. The broad ligament
B. The cardinal ligament
C. The uterus
D. The uterosacral ligament
RATIONALE: The uterus is a thick-walled, muscular, pear-shaped organ located between the bladder
anteriorly and rectum posteriorly. Its position and consistency make it readily identifiable on bimanual
examination.
4. A patient asks about the function of the fallopian tubes. Which description is most accurate?
A. Production of progesterone
B. Site of fertilization and early embryo transport to the uterus
C. Storage of mature oocytes
D. Production of cervical mucus
RATIONALE: The fallopian tube provides the environment for fertilization and transports the embryo
to the uterine cavity through ciliary action and muscular contractions. Tubal factor infertility accounts
for significant infertility cases.
5. Which layer of the uterus is responsible for cyclic shedding during menstruation?
A. Myometrium
B. Perimetrium
, C. Endometrium (functional layer)
D. Basalis layer
RATIONALE: The endometrium consists of a functional layer (superficial, shed during menses) and a
basalis layer (deep, regenerates the functional layer). Hormonal withdrawal triggers prostaglandin-
mediated vasoconstriction and shedding.
6. A patient with cyclic breast tenderness asks about the hormonal cause. Which hormone
combination is primarily responsible for breast changes during the luteal phase?
A. Estrogen alone
B. Progesterone alone
C. Estrogen and progesterone stimulation causing lobular-alveolar proliferation
D. Prolactin and oxytocin
RATIONALE: Cyclic breast tenderness results from combined estrogen and progesterone effects on
breast tissue during the luteal phase. Estrogen promotes ductal growth; progesterone stimulates
lobular-alveolar development, causing engorgement and tenderness.
7. Which structure produces the majority of circulating estrogen in premenopausal women?
A. Adrenal cortex
B. Ovarian theca and granulosa cells (through two-cell theory of estrogen synthesis)
C. Adipose tissue
D. Pituitary gland
RATIONALE: The two-cell theory describes estrogen synthesis where theca cells produce androgens
that are aromatized to estrogens by granulosa cells. This is the primary source of circulating estrogen in
premenopausal women.
8. A patient asks about cervical mucus changes during the menstrual cycle. Which description
characterizes ovulatory cervical mucus?
A. Thick, opaque, and sticky
B. Clear, stretchy, and watery with spinnbarkeit (ferning pattern)
C. Absent or scant
D. Bloody or brown-tinged
RATIONALE: Ovulatory cervical mucus is clear, stretchy (spinnbarkeit), and watery, forming a ferning
pattern when dried. These changes facilitate sperm transport and are markers of peak fertility.
9. A 28-year-old woman is diagnosed with polycystic ovary syndrome (PCOS). Which of the following
is the most appropriate first-line pharmacologic treatment for her hirsutism?
A. Spironolactone 100 mg daily
B. Combined oral contraceptive pills
C. Metformin 500 mg twice daily
D. Eflornithine cream twice daily
, RATIONALE: Combined oral contraceptive pills are first-line for hirsutism in PCOS because they
suppress ovarian androgen production and increase sex hormone-binding globulin, reducing free
testosterone. Spironolactone is an anti-androgen used as add-on therapy.
10. A 45-year-old woman with a history of venous thromboembolism (VTE) requests contraception.
Which method is contraindicated?
A. Copper intrauterine device
B. Levonorgestrel-releasing intrauterine system
C. Combined oral contraceptive pills
D. Etonogestrel subdermal implant
RATIONALE: Combined hormonal contraceptives are contraindicated in women with a history of VTE
(CDC MEC Category 4) due to increased thrombotic risk. Progestin-only and non-hormonal methods are
safer alternatives.
11. A 26-year-old female presents for contraceptive counseling. She notes a history of migraines that
are preceded by visual flashing lights and temporary blind spots. According to the CDC Medical
Eligibility Criteria, which of the following is the most appropriate recommendation?
A. Combined oral contraceptive pill
B. Contraceptive transdermal patch
C. Medroxyprogesterone acetate injection
D. Vaginal contraceptive ring
RATIONALE: Migraine with aura is a CDC MEC Category 4 condition for combined hormonal
contraceptives due to significantly increased ischemic stroke risk. Progestin-only options such as depot
medroxyprogesterone acetate are safe alternatives (Category 1 or 2).
12. A 31-year-old patient presents with a malodorous, thin, greyish-white vaginal discharge. Vaginal
pH is 5.2. Microscopic evaluation of the fluid mixed with 10% KOH yields a sharp, fishy odor. Which
microscopic finding confirms the most likely diagnosis?
A. Hyphae and budding yeast cells
B. Flagellated, motile trichomonads
C. Squamous epithelial cells covered in bacteria
D. Multicellular organisms with flagella
RATIONALE: The patient exhibits signs of Bacterial Vaginosis (BV), meeting Amsel criteria: thin
homogeneous discharge, vaginal pH greater than 4.5, and a positive whiff test. The definitive
microscopic finding for BV is clue cells—squamous epithelial cells with margins obscured by adherent
coccobacilli.
13. A primigravida patient at 26 weeks of gestation presents for her routine prenatal checkup. Which
laboratory screening should be scheduled during this gestational window?
A. Group B Streptococcus rectovaginal culture
B. 1-hour oral glucose challenge test (50-g load)
NEWEST 2026 TEST BANK| WOMEN’S HEALTH APEA FINAL
EXAM PREP WITH COMPLETE REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST
RECENT!!)
Core Domains
1. Reproductive Anatomy and Physiology
2. Contraception and Family Planning
3. Menstrual Disorders and Menopause
4. Gynecologic Infections and Sexually Transmitted Infections
5. Breast Health and Cervical Screening
6. Obstetrics: Prenatal Care and Pregnancy Complications
7. Structural Disorders, Sexual Health, and Primary Care Integration
8. Health Promotion and Preventive Care
9. Pharmacology and Therapeutic Interventions
10. Clinical Decision-Making and Diagnostic Interpretation
Introduction
This comprehensive assessment is designed to evaluate the knowledge, clinical judgment, and applied
decision-making required of a Women’s Health Nurse Practitioner preparing for the APEA Women’s
Health Final Examination. It rigorously tests foundational reproductive physiology, contraception,
menstrual disorders, menopause management, sexually transmitted infections, breast and cervical
health, prenatal care, obstetric complications, and primary care integration. The exam employs multiple-
choice and scenario-based questions emphasizing real-world clinical application, evidence-based
guidelines, and critical thinking. Mastery of these domains is essential for competent women’s health
practice and certification success.
SECTION ONE: QUESTIONS 1–350
1. A 24-year-old patient asks about the timing of ovulation in her menstrual cycle. Which hormone
surge triggers the release of the mature oocyte from the dominant follicle?
,A. Estrogen surge on day 7
B. Luteinizing hormone (LH) surge approximately 24–36 hours before ovulation
C. Progesterone surge during the luteal phase
D. Follicle-stimulating hormone (FSH) surge at menstruation
RATIONALE: The midcycle LH surge, triggered by rising estrogen levels from the dominant follicle,
induces final oocyte maturation and follicular rupture. This surge is the immediate trigger for ovulation
and can be detected by urine ovulation predictor kits.
2. A patient with primary amenorrhea has normal breast development but no pubic or axillary hair.
Which condition should be suspected?
A. 21-hydroxylase deficiency
B. 5-alpha reductase deficiency
C. Androgen insensitivity syndrome (46,XY karyotype with absent androgen receptor function)
D. Aromatase deficiency
RATIONALE: Androgen insensitivity syndrome presents with normal breast development (estrogen
from testicular aromatization) but absent androgen-dependent hair growth. Internal structures are
male; external genitalia appear female due to unresponsiveness to androgens.
3. During a pelvic examination, the provider palpates a firm, muscular structure between the bladder
and rectum. This structure is:
A. The broad ligament
B. The cardinal ligament
C. The uterus
D. The uterosacral ligament
RATIONALE: The uterus is a thick-walled, muscular, pear-shaped organ located between the bladder
anteriorly and rectum posteriorly. Its position and consistency make it readily identifiable on bimanual
examination.
4. A patient asks about the function of the fallopian tubes. Which description is most accurate?
A. Production of progesterone
B. Site of fertilization and early embryo transport to the uterus
C. Storage of mature oocytes
D. Production of cervical mucus
RATIONALE: The fallopian tube provides the environment for fertilization and transports the embryo
to the uterine cavity through ciliary action and muscular contractions. Tubal factor infertility accounts
for significant infertility cases.
5. Which layer of the uterus is responsible for cyclic shedding during menstruation?
A. Myometrium
B. Perimetrium
, C. Endometrium (functional layer)
D. Basalis layer
RATIONALE: The endometrium consists of a functional layer (superficial, shed during menses) and a
basalis layer (deep, regenerates the functional layer). Hormonal withdrawal triggers prostaglandin-
mediated vasoconstriction and shedding.
6. A patient with cyclic breast tenderness asks about the hormonal cause. Which hormone
combination is primarily responsible for breast changes during the luteal phase?
A. Estrogen alone
B. Progesterone alone
C. Estrogen and progesterone stimulation causing lobular-alveolar proliferation
D. Prolactin and oxytocin
RATIONALE: Cyclic breast tenderness results from combined estrogen and progesterone effects on
breast tissue during the luteal phase. Estrogen promotes ductal growth; progesterone stimulates
lobular-alveolar development, causing engorgement and tenderness.
7. Which structure produces the majority of circulating estrogen in premenopausal women?
A. Adrenal cortex
B. Ovarian theca and granulosa cells (through two-cell theory of estrogen synthesis)
C. Adipose tissue
D. Pituitary gland
RATIONALE: The two-cell theory describes estrogen synthesis where theca cells produce androgens
that are aromatized to estrogens by granulosa cells. This is the primary source of circulating estrogen in
premenopausal women.
8. A patient asks about cervical mucus changes during the menstrual cycle. Which description
characterizes ovulatory cervical mucus?
A. Thick, opaque, and sticky
B. Clear, stretchy, and watery with spinnbarkeit (ferning pattern)
C. Absent or scant
D. Bloody or brown-tinged
RATIONALE: Ovulatory cervical mucus is clear, stretchy (spinnbarkeit), and watery, forming a ferning
pattern when dried. These changes facilitate sperm transport and are markers of peak fertility.
9. A 28-year-old woman is diagnosed with polycystic ovary syndrome (PCOS). Which of the following
is the most appropriate first-line pharmacologic treatment for her hirsutism?
A. Spironolactone 100 mg daily
B. Combined oral contraceptive pills
C. Metformin 500 mg twice daily
D. Eflornithine cream twice daily
, RATIONALE: Combined oral contraceptive pills are first-line for hirsutism in PCOS because they
suppress ovarian androgen production and increase sex hormone-binding globulin, reducing free
testosterone. Spironolactone is an anti-androgen used as add-on therapy.
10. A 45-year-old woman with a history of venous thromboembolism (VTE) requests contraception.
Which method is contraindicated?
A. Copper intrauterine device
B. Levonorgestrel-releasing intrauterine system
C. Combined oral contraceptive pills
D. Etonogestrel subdermal implant
RATIONALE: Combined hormonal contraceptives are contraindicated in women with a history of VTE
(CDC MEC Category 4) due to increased thrombotic risk. Progestin-only and non-hormonal methods are
safer alternatives.
11. A 26-year-old female presents for contraceptive counseling. She notes a history of migraines that
are preceded by visual flashing lights and temporary blind spots. According to the CDC Medical
Eligibility Criteria, which of the following is the most appropriate recommendation?
A. Combined oral contraceptive pill
B. Contraceptive transdermal patch
C. Medroxyprogesterone acetate injection
D. Vaginal contraceptive ring
RATIONALE: Migraine with aura is a CDC MEC Category 4 condition for combined hormonal
contraceptives due to significantly increased ischemic stroke risk. Progestin-only options such as depot
medroxyprogesterone acetate are safe alternatives (Category 1 or 2).
12. A 31-year-old patient presents with a malodorous, thin, greyish-white vaginal discharge. Vaginal
pH is 5.2. Microscopic evaluation of the fluid mixed with 10% KOH yields a sharp, fishy odor. Which
microscopic finding confirms the most likely diagnosis?
A. Hyphae and budding yeast cells
B. Flagellated, motile trichomonads
C. Squamous epithelial cells covered in bacteria
D. Multicellular organisms with flagella
RATIONALE: The patient exhibits signs of Bacterial Vaginosis (BV), meeting Amsel criteria: thin
homogeneous discharge, vaginal pH greater than 4.5, and a positive whiff test. The definitive
microscopic finding for BV is clue cells—squamous epithelial cells with margins obscured by adherent
coccobacilli.
13. A primigravida patient at 26 weeks of gestation presents for her routine prenatal checkup. Which
laboratory screening should be scheduled during this gestational window?
A. Group B Streptococcus rectovaginal culture
B. 1-hour oral glucose challenge test (50-g load)
